Aneuploidy is a hallmark of most human tumors, but the molecular physiology of aneuploid cells is not well characterized. In this study, we screened cell surface biomarkers of ~300 proteins by multiparameter flow cytometry using multiple aneuploid model systems such as cell lines, patient samples and mouse models. Several new biomarkers were identified with altered expression in aneuploid cells, including overexpression of the cellular prion protein CD230/PRPC and the immunosuppressive cell surface enzyme ecto-5'-nucleotidase CD73.
Introduction
Aneuploidy refers to an abnormal chromosome number that differs from multiples of the haploid set. Due to its negative effect on cellular physiology, it is considered to be the leading cause of spontaneous miscarriages in humans and can cause pathological conditions such as trisomy syndromes (e.g. Down's syndrome, trisomy of chromosome 21) and mosaic variegated aneuploidy (1) . In addition, aneuploidy has also been tightly associated with cancer and, in contrast to cases with trisomy syndromes, malignant tumors often show variable aneuploid karyotypes with no apparent adverse effect on cell proliferation (2) . In fact, it has been hypothesized that aneuploidy in vivo facilitates tumorigenesis and generates phenotypic variation, thus providing a growth advantage under selective conditions (3, 4) .
Such phenotypic heterogeneity arises mainly from chromosomal instability (CIN), which is characterized by increased rate of loss/gain of whole chromosomes or parts thereof. In tumor cells, aneuploidy is often accompanied by CIN, which provides a mechanism to boost tumor progression due to emergence of cells with growth or survival advantages, the driving force of cancer development (5) . This might be the reason why, in many types of cancer, higher levels of aneuploidy have been associated with poor prognostic factors such as higher tumor grade, tumor recurrence, metastasis and decreased overall patient survival (6) .
The identification of biomarkers related to aneuploidy, or even to specific characteristics of aneuploid cells that may allow them to survive under specific conditions such as cellular stress, would not only increase our insight into its biological background, but would also facilitate the development of an early screening tool to detect and/or quantify aneuploidy in tumors, ultimately improving the clinical management of cancer patients. In line with this, a major focus of current research is to determine how cells respond to gene expression imbalances that are caused by aneuploidy (7, 8) . In the past years, global genome, transcriptome and proteome studies in aneuploid models as well as in cancers have provided new insights into the cellular response to aneuploidy (7) (8) (9) (10) (11) (12) (13) . Such studies indicate that copy number variations (CNV) of specific chromosomal regions can alter the expression of genes located on those regions. At the same time, aneuploidy per se can affect the transcription of many genes across the entire genome due to activation/inhibition of multiple pathways (11, 12) . Similarly, protein levels also scale with the gene copy number (CN), although it should be noted that some of the proteins coded on extra chromosomes Research.
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Author Manuscript Published OnlineFirst on April 4, 2017; DOI: 10.1158/0008-5472. are compensated by post-translational mechanisms that attenuate their levels when their encoding genes are in excess (e.g. subunits of macromolecular protein complexes and kinases) (7, 8) . However, the exact cellular and physiological responses to aneuploidy are incompletely understood. In the past years, several new models have been established in order to decipher the consequences of aneuploidy. These include mouse models (14) , human tri/tetrasomic cells generated by introducing one or more individual chromosomes into a host cell, and embryo-and patient-derived cell lines with trisomy syndromes (2) .
In this study, we aimed at identifying cell surface biomarkers correlated with an aneuploid karyotype by analyzing multiple models of aneuploidy for expression of approximately 300 proteins by multi-parameter flow cytometry (MFC). This approach allows for the measurement of multiple features on a single cell level and thereby a direct analysis of cell surface marker expression, which makes it a powerful method not only for the immunophenotypic characterization of cells, but also for the identification of novel biomarkers. In the study presented here, several new biomarkers have been identified to be associated with an aneuploid karyotype. Functional analysis showed that the main candidates were associated with the response to specific stress conditions, such as oxidative stress. Taken together, our findings provide novel tools to detect and analyze cells with aneuploid chromosome settings, as well as additional functional insight into the subsequent cellular stress arising in response to aneuploidy. 
Material and Methods

Cell lines, patients' fibroblasts and culture conditions
The aneuploid cell lines used as a model in the present study were generated from the parental cell line HCT116 (human colorectal carcinoma cell line) -HCT116 13/3 (trisomy 13; clones 2-3), HCT116 18/3 (trisomy 18; clones 1-2) and HCT116 21/3 (trisomy 21; clones 1 and 3) -, the parental cell line HCT116 H2B-GFP -HCT116 3/3 (trisomy 3; clones 11 and 13), and >4N -. All tri-and tetrasomic cell lines were generated by microcell mediated chromosome transfer (MCMT) as described previously and verified by sequencing (7, 11, 15, 16) . The post-tetraploid HPT and RPT cell lines were generated by expansion of individual tetraploid clones after inhibition of cytokinesis through dihydrocytochalasin D (DCD, Sigma-Aldrich, St. Louis, MO, USA) treatment, and the DNA content was confirmed by flow cytometry, standard karyotyping, chromosome painting and array comparative genomic hybridization as previously described (11, 17) . Additional tetraploid clones were generated previously by FACS-sorting of spontaneously arising tetraploids within the HCT116 population (18) . Diploid and tetraploid DLD1 cell lines were described previously (19) and spontaneously arising post-tetraploids were selected from the tetraploid population by FACS sorting, as described in detail elsewhere (20 and Viganó et al., unpublished) . All the cell lines were tested for mycoplasma contamination. for the cell surface marker screenings, followed by centrifugation at 300 g for 5 min.
Mouse models of aneuploidy
Mouse tumors were obtained from TetO-Her2, TetO-KrasG12D/MMTV-rtTA with and without Mad2 overexpression (21) as well as a new transgenic animal model TetO- (Venkateswaran et al. unpublished) . Single cells obtained from these tumors were injected into the cleared mammary fat pad of Rag2-/-mice (22) maintained on a doxycycline diet to regrow the primary tumor. Surgical procedures were performed under isoflurane inhalation (2.5% in 0.8 L/min, Esteve) and in accordance with local disinfection and sterilization guidelines. R1 and R15 tumors used in the study had a Kras genotype, R16 and R10 a Kras/Mad2, R4 and R5 a PLK1/Her2, and the R3 had a Her2 genotype. The tumors were genetically characterized as previously described (21) 
Cell surface marker screening of aneuploid cells
Cells were analyzed using the MACS® Marker Screen, human (Miltenyi Biotec, Bergisch Gladbach, Germany) containing 300 antibodies (Ab) APC-conjugated -291 antibodies specific for surface proteins plus 9 isotype controls ( Supplementary Table S1 ), arrayed in four Ubottom 96-well plates (one Ab/well). Before staining, lyophilized Abs were reconstituted with 25μL/well of deionized water. Cells were stained at a density of 0.5-2x10 5 cells per well in 50μL volume of PBS pH 7.2, 2 mM EDTA and 0,5% BSA (PEB) buffer at 2-8°C for 10 min, Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on April 4, 2017; DOI: 10.1158/0008-5472.CAN- instructions, and later gated in a V1(VioBlue)-A vs B1(FITC)-A plot. For those cell lines expressing H2B-GFP, only CellTrace™ Violet was used. Analysis was performed using the MACSQuant™ Analyzer and data analysis using the MACSQuatify™ software (Miltenyi Biotec).
Propidium iodide (PI, 1μg/mL) was used as viability dye. For validation screenings, a specific panel was established ( Supplementary Table S2 ) and cells were stained as previous with an antibody dilution of 1:10.
It is known that some aneuploid cell lines are larger than their euploid counterparts. In the flow cytometer used in our study, cells are investigated inside of a well-defined threedimensional region. This region is defined in one dimension by the hydrodynamically focused core stream carrying all cells with a diameter typically smaller than 15 µm. Cells can be larger than 15 µm in their natural environment or in an adherent state, however, when dissociated and put into a single cell suspension, cells round up and are significantly smaller. In the two other dimensions it is defined by the intersection of the laser excited volume and perpendicular to it by the volume imaged onto the light detector tubes (PMT). The resulting "observed volume" is in the order of 15 µm x 15 µm x 15 µm and has a fuzzy boundary. All fluorescence inside of that volume are taken into account for quantitation. The remaining unbound molecules within that volume, are quantified as well as all fluorescent molecules bound to the cell. The background signal is then subtracted from the signal collected while a cell is present. Thus, if there is a significant background contribution (e.g. by unbound fluorochrome-conjugates), a larger cell will displace more of that than a smaller cell. But other than that, the total fluorescence is detected independent from the cell size, as long as the cell fits completely in said observed volume. As a consequence, the measured signal is proportional to the total number of molecules bound to the cell, independent from cell-size.
To verify this theoretical prediction and to exclude a bias of the cell size on the fluorescence intensity of the cell surface marker staining, we have plotted FSC signals versus fluorescence signals and observed no correlation (data not shown). Concerning the issue of unbound dyes, unstained cells are the best control, since a larger unstained cell population will displace more unbound particles and as a consequence should have a lower (even negative) average mean fluorescence when compared to smaller cells. We included unstained controls for every cell line analyzed without observing this issue. Supplementary Table S3 ). 
siRNA-mediated knockdown
Flow cytometry-based analyses
To determine whether depletion of candidates had an effect on specific cellular functions, different analyses were performed. For cell cycle analysis, cells were fixed with 4% paraformaldehyde (PFA) 20min and stained with 1µg/mL DAPI in a 0.5% saponin solution for 
Induction and detection of specific stress conditions
To determine how specific stress conditions might affect cell growth, as well as the level of expression of candidate markers, aneuploid cells were exposed to serum-starvation, glucosedeprivation, high confluency, oxidative stress (H 2 O 2 ), or ER stress (Brefeldin, BFA; Thapsigargin, Thps; or Tunicamycin, TM). For this set of experiments, HCT116 18/3 (clones 1 and 2), HCT116 21/3 (clones 1 and 3) and HPT1 cell lines were used, together with HCT116 parental cell line as control.
To determine the effect of growth under high confluence, each cell line was plated in a 6well plate at a density of 2x10 5 cells per well and re-plated every 3 days (control) or 6 days (confluent) for 18 days. For the remaining stress conditions, cells were plated in a 6-well plate at a density of 2x10 5 cells per well and, after 24h, the medium was replaced by standard culture medium without FBS (serum-free) or without glucose (glucose-free), or treated with 100 µM H 2 O 2 , 1 μg/mL BFA, 0.25 μg/mL Thps or 2.5 μg/mL TM (all purchased from Sigma-Aldrich), for 2-3 days. After treatment, cells were collected and stained with Abs for the specific markers selected, at a dilution 1:10 at 2-8°C for 10 min, followed by 2 washing steps with PEB.
For oxidative stress detection, the CellROX® Deep Red Reagent (Life Technologies) was used to evaluate the levels of reactive oxygen species (ROS) by flow cytometry. For this purpose, the medium was removed from each well and cells were re-incubated with CellROX® Reagent at a final concentration of 5 μM, 30min at 37°C, before analysis. For ER detection, cells were stained 30min with anti-PDI PE antibody (clone 1D3, 1:100, Abcam, Cambridge, 
Results
Identification of differentially expressed cell surface markers in aneuploid cells
Two adherent parental cell lines, RPE1 and HCT116, were used to generate cells with an aneuploid karyotype by transferring an additional chromosome via microcell-mediated chromosome transfer (to induce trisomy of chromosome 5, 12, 21 or others), or by inhibiting cytokinesis to generate more complex karyotypes (post-tetraploidy) ( Figure S1 ). We measured the mean fluorescence intensity and percentage of positive cells for each surface marker staining across different cell lines ( Supplementary   Table S4 ). Analysis of the expression pattern showed 72/291 proteins with altered levels of expression in at least two of the aneuploid karyotypes when compared to the control (HCT116 and RPE1 parental cells); 20 and 18 of the 72 markers were altered in terms of mean intensity value and/or percentage of positive cells in five and four of the screened aneuploid cell lines, respectively. Based on these results, a new 49-marker panel (with additional 5 isotype control antibodies) with the most important candidates was developed for further analyses ( Supplementary Table S2 ).
Validation of candidate markers in independent cell lines
In order to validate the most relevant candidates identified in the two initial high-throughput screenings, 25 additional aneuploid cell lines with different karyotypes were analyzed (e.g. Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
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For the majority of the clones analyzed in this study, at least two repetitive screenings were performed, with a total of 74 analyses for a total 35 Supplementary Table S5 . and both integrins were also upregulated in aneuploid cells that contain independent chromosomal amplifications. This indicates that there is only a minor role for chromosomal location and that the upregulated markers represent rather a response to aneuploidy per se.
Taken together, we have identified 15 markers which are expressed at higher levels in human aneuploid cells than in the corresponding diploids in at least 60% of all analyzed lines.
The elevated expression was independent of the cell line, the identity of the extra chromosome or the origin of aneuploidy.
As marker detection by multiparameter flow cytometry was performed at the cell surface level, we used previously published proteome data (7) Table S6 ). These data confirmed an increased abundance of most of the candidates, including increased expression of CD230 (PRNP), CD73 (NT5E), CD318 (CDCP1), CD298 (ATP1B3), as well as the CD49b, CD29 and CD51 integrins, in at least five of the six aneuploid cell lines compared to their diploid counterparts.
The overexpression of identified biomarkers is reproduced in primary fibroblasts from patients with trisomy syndromes and mouse models of aneuploidy
To determine whether the differential expression of the identified candidate markers was also associated with aneuploidy in primary cases of trisomy syndromes, fibroblasts from patients with Down's (trisomy 21), Edwards' (trisomy 18) and Patau's (trisomy 13) syndromes were analyzed for the 49 surface markers. When compared with normal fibroblasts, patient samples showed overexpression of several markers, such as CD55 (12/12 screenings), CD58 (12/12), CD99 (12/12), CD230 (11/12), CD90 (11/12), CD95 (10/12), CD97 (10/12), CD147 (10/12), CD10 (10/12), CD73 (9/12) and PTk7 (9/12), in at least 5 of the 6 patients ( Figure 2B ). Of note, similarly as in model aneuploidy cell lines, CD54 was one of the Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
most frequent markers (8/12 screenings) showing decreased expression in patients'
fibroblasts when compared to the normal counterparts.
In more detail, comparisons among aneuploid cell lines and patients' fibroblasts showed an increased expression of CD97, CD276, CD298, CD29, CD147, CD49e, CD49b and HLA-Bw6, as well as decreased expression of CD54 in cell lines with a trisomy of chromosome 13. Cells with trisomy 18 showed a common increased expression of CD55, CD58, CD99 and CD138, in addition to a decreased expression of CD142. On the other hand, trisomy of chromosome 21 showed higher CD119, CD147 and HLA-Bw6 and lower CD54 expression, on both aneuploid cells and patients' fibroblasts.
To further validate the candidate markers in a completely independent model system, we additionally analyzed an in vivo mouse breast cancer model of chromosomal instability. We used a previously generated mouse mammary tumor virus (MMTV)-driven, doxycyclineinducible model (21,23), which overexpress Kras G12D or both Mad2 and Kras G12D , since the later tumors have been shown to be highly aneuploid (21). To complement our study, we also used mouse tumors overexpressing Her2 or both Supplementary Table S7 ). In addition, higher levels of expression were also detected in the high-aneuploidy tumors when compared to the low-aneuploidy ones, for several members of the integrin (i.e. CD29, CD47, CD49f and CD104) and tetraspanin (i.e. CD9, CD63 and CD151) family of proteins ( Supplementary Table S7 ). Taken together, these results strongly indicate that the identified markers are generic and broadly applicable across aneuploid cells in the human and murine settings. 
Expression of CD230 and CD73 in aneuploid cells changes in response to cellular stress
To characterize possible roles of the identified markers on aneuploidy, 6 candidates -the major prion protein (CD230), the ecto-5'-nucleotidase (CD73), the CD55 complement regulatory protein, the CD95 Fas receptor and two members of the integrin family of proteins (CD49b and CD47) -were selected for further functional analyses. Depletion of the candidates by siRNA-mediated knockdown showed no major effect on cell proliferation (% EdU + cells) and cell death (%AnnexinV + cells), when compared to the non-targeting siRNA control on both the HCT116 parental and HPT1 cells (Supplementary Figure S3) . Therefore, the expression of those markers seems to be non-essential for the cells, at least over limited period of time and under the tested conditions. We next investigated whether the expression of selected candidates correlates to specific stress conditions known to affect aneuploid cells. Aneuploidy is known to induce cellular stress (24) and recent reports suggest an association between aneuploidy and an advantageous phenotype under stress conditions (3) . Aneuploid clones with negative or low expression of the markers (HCT116 18/3 cl2 and 21/3 cl1 and 3) were compared to clones with high levels of expression (HPT1 and HCT116 18/3 cl1), as well as HCT116 parental cells as control. The investigated stress conditions included growth at a high confluency, serumstarvation, glucose-deprivation, oxidative stress and ER stress. To evaluate whether the stress conditions could alter the expression of those candidates, cells were initially grown under high confluency. Results showed a significant increase in the percentage of CD73 + cells for both HCT116 21/3 clones (p<0.0001, 0 vs 6, 6 vs 12 and 12 vs 18 days) compared to parental cells (p<0.0001, 0 vs 6 days) ( Figure 4A ). Of note, parental cells showed only a slight initial increase in the percentage of CD73 + cells, which stabilized over the time period of the experiment (Figure 4A and B) . This indicates that the stress response and corresponding CD73 expression is significantly increased in aneuploid setting.
We next analyzed whether cells with different degrees of aneuploidy show correlating levels of ER or oxidative stress. Whereas no significant differences were found for clones with only one extra chromosome, near-tetraploid clones, associated with higher levels of aneuploidy, showed higher expression of the ER stress marker protein disulfide isomerase (PDI), as well as higher reactive oxygen species (ROS), when compared to parental cells (p<0.01; Figure 5A and B). To further evaluate the impact of ER stress on aneuploid cells, we determined the Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on April 4, 2017; DOI: 10.1158/0008-5472. effect of glucose-deprivation, 1ug/mL brefeldin A, 0.25ug/ml thapsigargin or 2.5ug/mL tunicamycin on the expression levels of the candidates. However, results suggested a general decrease for mean fluorescence intensity of the cell surface markers, as the treatment probably blocked the assembly of new proteins in the ER and/or the transport of proteins from the ER to the cell surface ( Supplementary Figure S4) . To test the effect of oxidative stress, we treated cells with 100µM H 2 O 2 , a commonly used method to induce oxidative stress in cells (25) . We observed a general increase for all analyzed proteins, most particularly for the CD95 FAS receptor, possibly due to the high toxicity of the treatment (Supplementary Figure S5) .
In addition, we tested the response of cells to 3 days of FBS-starvation as an alternative approach to induce oxidative stress with lower toxic effects (26) . Indeed, the results revealed that serum-starvation (0% FBS), but not glucose-deprivation increased the generation of ROS in both parental and aneuploid cells (p<0.01 vs cells growing under 10% FBS; Figure 5C ). The increased ROS resulted in an increase in the mean fluorescence intensity and/or percentage of positive cells of CD73, CD49b, CD95, and CD230, with CD230 showing the most significant increase ( Figure 5D ). Furthermore, all clones showing an intermediate expression of CD230 became CD230 positive (HCT116 18/3 cl2, HCT116 21/3 cl1 and 3, as well as HCT116 wildtype), while those clones already expressing CD230 (HPT1 and HCT116 18/3 cl2) showed a significant increase in the mean intensity level (p<0.001 vs 10% FBS control cells; Figure 5D and Supplementary Figure S6) . These results suggest that serum-starvation increases the expression of CD230 in response to increased oxidative stress. Subsequent depletion of CD230 by siRNA-mediated knockdown followed by 3 days of FBS-starvation showed no significant effect on cell proliferation (data not shown), but a significant increase in the percentage of necrotic DAPI + HPT1 aneuploid cells compared to the non-targeting siRNA control (p<0.001; Figure 5E ). A slight, but not significant increase of necrosis as well as elevated percentage of apoptotic (Annexin V + ) cells was also detected in HCT116 parental cells. These results confirm an important role of CD230 in cell survival upon oxidative stress, which is further emphasized in cells already compromised by aneuploidy.
Taken together, our data indicate that overexpression of the identified cell surface markers, particularly CD230 and CD73, is correlated to cellular stress, which is increased in cells with aneuploid chromosome settings and might confer survival advantages under stress conditions.
Research.
Discussion
The possible impact of aneuploidy on human health has been recognized for over a century, but its effects at the cellular level, such as the specific phenotype arising from aneuploidy, have only become a focus in more recent studies (2) . Moreover, transcriptome and proteome analysis revealed common expression changes, suggesting the possibility that some of these changes might be used as markers of aneuploidy. In the present study, we applied a novel cell surface marker screening analysis to evaluate the expression pattern of 291 proteins in order to identify biomarkers related to aneuploidy. Using this strategy we aimed not only to determine surface marker candidates, which would allow to detect and/or quantify aneuploidy in tumors, but also to provide insights into the underlying mechanisms that allow the cells with aneuploid karyotypes to grow despite the detrimental effects of aneuploidy on cellular physiology. To ensure a broad coverage of aneuploidy types, cells with one or two extra chromosomes (7) , near-tetraploid karyotypes (17) , embryo-and patient-derived cell lines with trisomy syndromes, as well as mouse models of aneuploidy (14) were all included in this study and screened for their surface proteome.
Using this approach, we identified several proteins upregulated in aneuploid cells when compared to the corresponding diploid parental cells. Remarkably, the strongest candidates included proteins which have been previously associated with cancer, namely the prion protein (PrP C , CD230) (27), the ecto-5'-nucleotidase (ecto-5'-NT, CD73) (28), the CUB domain-containing protein CD318 (29), the Na + /K + -ATPase subunit CD298 (30), the disintegrin-metalloproteinase ADAM10 (CD156c) (31), the complement regulatory proteins CD46 and CD55 (32), the CD58 and CD99 cell adhesion molecules, the basigin (CD147) (33), as well as several members of the integrin family of proteins, e.g. CD29, CD49b, CD47, CD49f and CD104, which are expressed by tumor and tumor-associated host cells to mediate a diverse array of cellular effects resulting in tumor progression and metastasis (34) .
Interestingly, expression of several of these markers, such as CD230, CD73, CD55, CD58, CD99, was also elevated in primary fibroblasts from patients with Down's (trisomy 21), Edwards' (trisomy 18) and Patau's (trisomy 13) syndromes when compared to normal fibroblasts, thus suggesting a possible role for these proteins in aneuploid settings independent of cancer.
Author Manuscript Published OnlineFirst on April 4, 2017; DOI: 10.1158/0008-5472.CAN- Using mouse models of aneuploidy, we further found that aneuploid mouse breast tumor cells also overexpress several of the identified candidate proteins such as the CD73 enzyme and multiple members of the integrin family of proteins. Interestingly, while the ecto-5'-NT enzyme was absent on both normal mammary gland cells as well as in non-tumoral lineages, all aneuploid tumors derived from four different mouse models (Kras G12D , Kras G12D /Mad2, Her2, and Her2/PLK1) harbored a subpopulation of tumor cells defined by the expression of this marker that ranged from 30% to 100 % of the tumor. Moreover, the expression levels often scaled with the degree of aneuploidy: the most aneuploid tumor (R10) showed the highest levels of CD73 expression while tumors with lower CNV showed only intermediate expression of CD73 in comparison to diploid cells. Of note, it is important to consider that not all the antibodies had a mouse specific counterpart (29 mouse/49 human specific Abs), thereby the expression intensity of some of the markers could not be validated in the respective mouse models.
When taking all used models into account, two markers -PrP C and ecto-5'-NT -particularly stand out due to their low or absent expression in diploid cells, while the majority of the aneuploid cells showed a positive subpopulation, with variable percentages among the different clones and models ( Figure 1F and I) . PrP is well known for its role in the pathogenesis and transmission of prion diseases. Despite the abundant information on the function of the misfolded prion protein (PrP Sc ), the function of the cellular prion protein (PrP C ) remains largely unknown (27) . However, multiple reports have suggested a putative role for PrP C in cell signaling, survival, and differentiation (27, 35, 36) and, more recently, a large body of evidence suggests that PrP C is overexpressed in different types of cancers and its expression appears to be associated with poor prognosis and resistance to therapy (37) (38) (39) (40) (41) . Similarly, the ecto-5'-NT/CD73, a membrane-bound enzyme that catalyzes the hydrolysis of AMP into adenosine and phosphate, has also been found to be overexpressed in many types of cancer (28) , with multiple key roles in tumor development. CD73 can act as a signal and adhesive molecule that regulates cell interaction with extracellular matrix components (e.g. laminin and fibronectin) to mediate cancer invasiveness and metastatic properties, as well as playing a key important role in the tumor immunoescape due to CD73-generated adenosine (42) . In line with such evidences, our results suggest that increased surface abundance of these proteins may contribute to the phenotypic changes observed in aneuploid cells. Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on April 4, 2017; DOI: 10.1158/0008-5472. It is currently known that the aneuploid state of the cell elicits several cellular stress responses such as proteotoxic (24, 43) and oxidative stresses (44) . How these "aneuploidyassociated stresses" affect cells and how cells respond to them are not yet clear (24, 43) . The possibility that aneuploidy triggers such stress responses in order to adapt and proliferate with their altered genomes has been recently proposed (24) . In fact, evidences show that the effects of aneuploidy may become advantageous under environmental stress, most possibly due to the karyotypic/phenotypic heterogeneity arising in aneuploid cell populations caused by chromosomal instability, which ultimately provides superior adaptability and a growth advantage under selective conditions (24, 45) . Based on this, and due to the lack of an effect of marker-depletion on cell proliferation and cell death (apoptosis), we hypothesize that the expression of the marker candidates may be related to cellular stress. Indeed, our results showed that high levels of aneuploidy (i.e. the neartetraploid clones) were correlated with higher levels of both ER and oxidative stress. Most strikingly, clones with an extra copy of chromosome 21, which were initially negative for CD73, strongly increased the expression of CD73 + cells when grown under high confluency, while parental diploid cells only slightly increased expression early on and stabilized over time. A high confluency environment most certainly leads to hypoxia, a condition known to promote selection of resistant, aggressive cancer cells able to survive in unfavorable environments, with greater proliferative and migratory capacity (46) . Accordingly, CD73 expression can be driven by an hypoxic microenvironment as the CD73 gene promoter has at least one binding site for the hypoxia-inducible factor-1α (42, 47) in order to convert AMP to adenosine and, consequently, to enhance tumor survival (46) . Thus, we hypothesize that aneuploid cells might overexpress the ecto-5'-NT enzyme as a mechanism to gain protection under specific conditions and to support proliferation. In addition, under serum-free conditions both parental and aneuploid cells highly increased the expression of PrP C , as well as the generation of ROS, indicating that the higher levels of PrP C expressed by aneuploid cells (compared to normal cells) can probably confer an advantage against oxidative stress.
Indeed, we found that aneuploid cells showed increased cell death under serum starvation after depletion of PrP C . These results are consistent with one of the emerging functions reported for PrP C , its protective role for cell survival, including protection against oxidative stress and serum deprivation (36) , as well as hypoxia (48) . In addition, PrP C has been described as an important modulator of tumor growth via engagement to the ligand HSP70/90 heat shock organizing protein (49) . Interestingly, Bravard et al. (50) also reported recently a key role of PrP C in the DNA damage response, suggesting that PrP C is required to maintain genomic stability in response to genotoxic stress. The authors showed that exposure to genotoxic stress activates PRNP transcription and increases the amount of PrP C in the nucleus, where it stimulates the endonuclease APE1, essential for base excision repair.
Such evidences, together with our data, suggest that aneuploid clones might overexpress PrP C in order to increase protection from oxidative stress as well as DNA damage and, consequently, increase survival of aneuploid clones. Based on these data we propose that the identified changes in surface proteins reflect the cellular response to aneuploidy that is independent of the chromosome composition or the cell type. These proteins likely facilitate growth of aneuploid cells by protecting them from endogenous stresses caused by unbalanced karyotype.
In summary, we have identified multiple cell surface biomarkers with altered expression in aneuploid cells. The most striking and general overexpression was seen for the CD230/PrP C protein and the enzyme CD73/ecto-5'-NT. Furthermore, we have shown that overexpression of both markers in aneuploid cells is associated to increased cellular stress, which may help to explain how aneuploidy confers a selective advantage to cells. CD230 and CD73 may therefore represent key markers to detect aneuploidy in healthy as well as tumor samples.
Further studies to understand the full impact of these markers on aneuploid cells will not only deepen our knowledge on the consequences of an abnormal karyotype, but will also increase our insight into disabilities such as Down's syndrome and diseases such as cancer. 
